Alternatives to C2i Genomics

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Natera is a global leader in cell-free DNA testing, providing genetic testing services for reproductive health, oncology, and organ transplantation.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

A molecular diagnostics company focused on integrating genomics with personalized therapeutic approaches for cancer.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

AI-powered blood analysis for precise substance tracing and classification in healthcare and research.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Provides AI-powered data analysis solutions for molecular diagnostics and research, streamlining qPCR data interpretation.

Advanced diagnostics for preventative health and personalized cancer treatment using AI and genomics.

AI-powered blood test for early cancer detection and subtyping.

AI-driven diagnostics that convert medical images into actionable genomic insights for faster cancer treatment decisions.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

AI-powered spatial biology platform for precision medicine and drug development.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Bioinformatics platform for rapid discovery and validation of precision mental health treatments.

Personalized nutrition and metabolic health platform using gut microbiome and AI.

Personalized diagnostics for cancer genomic markers at the point of treatment.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Harnessing genetic data for digital insights in rare and germline disorders.

MedHub-AI develops an AI-based decision support system for interventional cardiologists to enable precision cardiac care.

A platform for functional, integrative, and longevity medicine.

Infiniplex offers a comprehensive cancer screening platform utilizing advanced AI and multi-omic analysis.

Digital pathology imaging technology and AI-driven precision pathology software.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Igentify is a digital health company providing a Digital Genetic Assistant platform for clinicians, laboratories, and patients.

Develops AI-powered decision support tools for personalized medical data interpretation and prediction.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Liger Medical develops breakthrough optical diagnostic devices and software for early cancer detection and other medical purposes.

A medical platform connecting patients and physicians with genetic expertise.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

PixCell Medical develops and commercializes point-of-care blood diagnostic solutions for rapid and accurate results.

Transforming healthcare by turning scientific fiction into scientific facts.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered breast cancer detection and risk assessment solutions.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Amendis develops an AI-powered test to assess the risk of tumor spread in the neck, aiming to prevent unnecessary surgeries.

Scalable, one-time curative in-vivo gene editing therapies.

Develops a computational model of the human body for drug discovery and development.

A leading children's research hospital dedicated to treating and curing childhood catastrophic diseases.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

Sight Diagnostics develops rapid, accurate, and convenient diagnostic testing solutions, including a complete blood count analyzer.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Digital leader in preventive heart health using connected devices and AI coaching.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

Scopio Labs transforms cell morphology analysis with fully digital platforms and diagnostic support for faster, more accurate disease detection.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

AI-powered personalized screening for early disease detection using non-invasive methods.